# Psychometric network analysis of depression in hypertensive older adults: identifying core symptoms and modifiable risk factors

**Authors:** Yue Li, Fengdan Chen, Lanxian Mai, Haibin Luo, Zhiyu Zeng

PMC · DOI: 10.3389/fpsyt.2026.1751228 · Frontiers in Psychiatry · 2026-02-04

## TL;DR

This study maps depression symptoms in elderly hypertensive patients, identifying anhedonia as a key symptom and highlighting modifiable factors like exercise and resilience.

## Contribution

The paper introduces a depression symptom network in elderly hypertensive patients, identifying central symptoms and modifiable risk factors.

## Key findings

- Anhedonia (PHQ1) is the most central symptom in the depression network.
- Depression, anxiety, and insomnia are strongly interconnected.
- Resilience dimensions negatively correlate with depressive symptoms, while exercise is linked to insomnia and demographics.

## Abstract

This study aims to construct a depression symptom network in elderly hypertensive patients, identify central and bridging symptoms, and explore the association between network structure and modifiable risk factors.

This study adopts a retrospective research design, reviewing the medical records and survey data of 562 elderly hypertensive patients from a tertiary comprehensive hospital from September 2022 to May 2023. The data was retrospectively collected from patient health records including a general demographic questionnaire, Insomnia Severity Index-7(ISI-7), 9-item Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), and Connor Davidson Resilience Scale-25 (CD-RISC-25). Calculate centrality indices (intensity, betweenness centrality, and intimacy) to identify core symptoms. A comprehensive network model integrating GAD-7, ISI-7, CD-RISC-25, and demographic variables was constructed.

A total of 562 patients were enrolled in the study. The average score of PHQ-9 is (10.69 ± 3.42) points. Network analysis shows that anhedonia (PHQ1) exhibits the highest intensity centrality. The strongest partial correlation was observed between Sleep problems(PHQ3) and PHQ1 (weight=0.40), fatigue (PHQ4) and depressed mood (PHQ2) (weight=0.29), and PHQ4 and PHQ1 (weight=0.29). There are two different symptom clusters: somatic affective clusters (PHQ1, PHQ3, PHQ4) and cognitive vegetative clusters (appetite problems(PHQ5), feeling of worthlessness (PHQ6), concentration problems (PHQ7)). Suicide ideation (PHQ9) exhibits the lowest centrality. The comprehensive network model indicates a strong positive correlation between depression and anxiety (PHQ-GAD), depression and insomnia (PHQ-ISI), and anxiety and insomnia (GAD-ISI). The dimensions of psychological resilience, including self reinforcement, resilience, and optimism, are negatively correlated with PHQ scores (all P<0.001), while GAD-7 scores are positively correlated. There are edge connections between exercise (EX) and ISI, disease course (DU), and gender (GD). Drink (DR) is positively correlated with GD, while degree of education (DOE) is connected within demographic clusters and has an edge with GD.

Network analysis revealed that in the depressive network of patients with hypertension, anhedonia is the most central symptom, indicating that it may become a primary intervention target. The comprehensive network uncovered significant interconnections among depression, anxiety, and insomnia. Furthermore, the resilience dimension negatively correlates with depressive symptoms, while there are edge connections between exercise and both insomnia and demographic factors, highlighting modifiable protective factors.

## Linked entities

- **Diseases:** depression (MONDO:0002050), anxiety (MONDO:0005618), insomnia (MONDO:0013600)

## Full-text entities

- **Diseases:** white matter hyperintensities (MESH:D056784), Suicidal ideation (MESH:D001072), Fatigue (MESH:D005221), stroke (MESH:D020521), AIS (MESH:D000083242), emotional disorders (MESH:D009358), Concentration difficulties (MESH:C567712), difficulty (MESH:D051346), HL (MESH:C538324), Sleep disorders (MESH:D012893), anhedonia (MESH:D059445), Insomnia (MESH:D007319), Alzheimer's disease (MESH:D000544), mental disorders (MESH:D001523), changes (MESH:D009402), GD (MESH:D019968), anxiety (MESH:D001007), Depressed mood (MESH:D003866), bipolar disorder (MESH:D001714), Appetite problems (MESH:D001068), cognitive decline (MESH:D003072), dopaminergic (MESH:D009422), microvascular lesions (MESH:D017566), Generalized Anxiety Disorder (MESH:C000726808), Hypertension (MESH:D006973), cardiovascular conditions (MESH:D002318), myocardial infarction (MESH:D009203), ischemic stroke (MESH:D002544), COVID-19 (MESH:D000086382), vascular damage (MESH:D057772), mental health disorders (OMIM:603663)
- **Chemicals:** alcohol (MESH:D000438), EVT (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913080/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913080/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913080/full.md

---
Source: https://tomesphere.com/paper/PMC12913080